<qa>  What is the primary objective of the questionnaire?1.2. Secondary Objectives 1. To evaluate the efficacy of B244 in participants with mild to moderate acne vulgaris from baseline to weeks 2, 4, 8, and 16: i Reduction in inflammatory and non-inflammatory lesion count ii IGA success iii Improvement in patient reported quality of life score using the Skindex-16 questionnaire 